This presentation by esteemed experts, Dr. Fouad Alnajjar and Dr. Shouki Bazarbashi, delves into the urgent matter of prostate cancer in Saudi Arabia. The alarming statistics reveal a remarkable 30% rise in incidence over the past decade, warranting immediate attention. The speakers shed light on the significance of shared decision-making in screening, specifically emphasizing the target age group of 55 and above, who should undergo annual PSA blood tests.
A comprehensive overview of treatment options for localized prostate cancer is presented, encompassing active surveillance, surgery, and radiation therapy, while advanced metastatic cases predominantly rely on potent hormonal therapies. The crucial role of pharmacists in patient care is acknowledged, with a focus on managing side effects, monitoring bone health, and offering essential lifestyle guidance. With a resolute emphasis on early detection and holistic patient care, this compelling presentation serves as a rallying call in the fight against prostate cancer in Saudi Arabia.
This program is supported by Novartis.